Relay Therapeutics, Inc. RLAY Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from Relay Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Relay Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relay Therapeutics, Inc.'s free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relay Therapeutics, Inc.'s free cash flow margin?
- Relay Therapeutics, Inc. (RLAY) reported free cash flow margin of -1,536% in Q4 2025.
- How has Relay Therapeutics, Inc.'s free cash flow margin changed year-over-year?
- Relay Therapeutics, Inc.'s free cash flow margin increased by 38.8% year-over-year, from -2,509.5% to -1,536%.
- What is the long-term trend for Relay Therapeutics, Inc.'s free cash flow margin?
- Over 5 years (2020 to 2025), Relay Therapeutics, Inc.'s free cash flow margin has grown at a 64.8% compound annual growth rate (CAGR), from -126.3% to -1,536%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.